FDA Misses Congressionally Mandated Deadline to Publish Cannabinoid Lists

If the FDA can’t even define which cannabinoids are legal, the hemp CBD products you rely on could disappear without warning when the November 2026 ban takes effect. The FDA has missed its Feb 10 deadline to publish lists of naturally occurring cannabinoids, THC-class compounds, and those with ‘similar effects.’ The lists were mandated by Congress under the Nov 2025 spending bill. HHS told reporters it intended to meet the deadline, but nothing has materialized.

Read More